Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells and plasmablasts as hallmarks of severe COVID-19 trajectories . Bernardes et al

Published: 20 November 2020| Version 2 | DOI: 10.17632/7686ww5z33.2
Contributors:
Neha Mishra,
,
,

Description

Supplemental Tables for publication Longitudinal multi-omics analysis identifies responses of megakaryocytes, erythroid cells and plasmablasts as hallmarks of severe COVID-19 trajectories  Joana P. Bernardes+, Neha Mishra+, Florian Tran+, Thomas Bahmer, Lena Best, Johanna I. Blase, Dora Bordoni, Jeanette Franzenburg, Ulf Geisen, Jonathan Josephs-Spaulding, Philipp Köhler, Axel Künstner, Elisa Rosati, Anna C. Aschenbrenner, Petra Bacher, Nathan Baran, Teide Boysen, Burkhard Brandt, Niklas Bruse, Jonathan Dörr, Andreas Dräger, Gunnar Elke, David Ellinghaus, Julia Fischer, Michael Forster, Andre Franke, Sören Franzenburg, Norbert Frey, Anette Friedrichs, Janina Fuß, Andreas Glück, Jacob Hamm, Finn Hinrichsen, Marc P. Hoeppner, Simon Imm, Ralf Junker, Sina Kaiser, Ying H. Kan, Rainer Knoll, Christoph Lange, Georg Laue, Clemens Lier, Matthias Lindner, Georgios Marinos, Robert Markewitz, Jacob Nattermann, Rainer Noth, Peter Pickkers, Klaus F. Rabe, Alina Renz, Christoph Röcken, Jan Rupp, Annika Schaffarzyk, Alexander Scheffold, Jonas Schulte-Schrepping, Domagoj Schunck, Dirk Skowasch, Thomas Ulas, Klaus-Peter Wandinger, Michael Wittig, Johannes Zimmermann, Hauke Busch*, Bimba F. Hoyer*, Christoph Kaleta*, Jan Heyckendorf*, Matthijs Kox*, Jan Rybniker*, Stefan Schreiber*, Joachim Schultze*, Philip Rosenstiel*, HCA Lung Biological Network and the Deutsche COVID-19 Omics Initiative (DeCOI) +          Equal contribution first authors *          Senior authors Table S1. Detailed clinical characteristics of the patients included in cohort1 (related to Figure 1) Table S3. List of genes assigned to each co-expression module (related to figure 4)

Files

Categories

RNA Sequencing, COVID-19

Licence